Fate Therapeutics Inc

NEW
STU:F6T (USA)  
€ 2.206 +0.034 (+1.57%) Aug 14
At Loss
P/B:
1.95
Market Cap:
€ 266.47M ($ 308.24M)
Enterprise V:
€ 198.76M ($ 229.92M)
Volume:
6.50K
Avg Vol (2M):
3.80K
Trade In:
Volume:
6.50K
At Loss

Fate Therapeutics Inc (STU:F6T) Dividend

Fate Therapeutics Inc (STU:F6T) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:F6T Dividend

Does Fate Therapeutics Inc (STU:F6T) pay a dividend?

Fate Therapeutics Inc (STU:F6T) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Fate Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Fate Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -5.8% over the past 3 years.

What are dividend-paying alternatives to Fate Therapeutics Inc?

For dividend-paying alternatives in Fate Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.